
Genetics of Epilepsy and Refractory Epilepsy - Paperback
$39.99
$40.00
Quantity
01
Pay over time for orders over $35.00 with
Offers & Perks
Earn 39 points with this purchase
Added to your rewards balance after checkout.
100 points welcome bonus
Create an account and start with extra points.
Availability:In StockContributor:Alberto Lazarowski, Liliana CzornyjSeries:Colloquium Lectures on Genetic Basis Human DiseasePublish date:3/1/2013Pages:119
Languages:EnglishPublisher:Morgan & ClaypoolISBN-13:9781615045327ISBN-10:1615045325UPC:9781615045327Book Category:Science, MedicalBook Subcategory:Life Sciences, DiseasesBook Topic:Genetics & Genomics, Molecular BiologySize:9.25 x 7.50 x 0.25 inchesWeight:0.218Product ID:SCT28SNZCR
Epilepsy affects approximately 3% of the population, and is usually defined as a tendency to experience recurrent seizures arising from periodic neuronal hyperexcitability of unknown causes. Different genetic factors, through various mechanisms, can cause this abnormal neuronal behavior. The etiology of epilepsy is a major determinant of clinical course and prognosis. Many of the genes that have been implicated in idiopathic epilepsies code for ion channels, whereas a wide spectrum of syndromes where epilepsy is a main clinical feature are caused by mutated genes that are involved in functions as diverse as cortical development, brain malformations, mitochondrial function, and cell metabolism. Similarly, different conditions as hypoxia, trauma, infections, or metabolic unbalances can develop epileptic syndromes where upregulation of several genes could be related to the epileptogenic mechanisms. The most common human genetic epilepsies display a complex pattern of inheritance, and the susceptible genes are largely unknown. However, major advances have recently been made in our understanding of the genetic basis of monogenic inherited epilepsies. As we continue to unravel the molecular genetic basis for epilepsies, it will increasingly influence their classification and diagnosis. A majority of epileptic patients may control their crisis with anticonvulsant drugs, however 30%-40% became refractory to pharmacological therapies and require surgical treatment. The challenge of the molecular revolution will be the design of the best treatment protocols based on genetic profiles that include both the specific mechanistic etiology of the epilepsies, as well as their potential refractory behavior to current medications. This includes also the design of new therapeutic agents and targets, so as to reduce the number of cases with refractory epilepsy and epileptogenesis, and perhaps avoid the current surgical treatment (a procedure that was first described more than 4000 years ago) except as a last option.
Languages:EnglishPublisher:Morgan & ClaypoolISBN-13:9781615045327ISBN-10:1615045325UPC:9781615045327Book Category:Science, MedicalBook Subcategory:Life Sciences, DiseasesBook Topic:Genetics & Genomics, Molecular BiologySize:9.25 x 7.50 x 0.25 inchesWeight:0.218Product ID:SCT28SNZCR
Publisher: Morgan & Claypool
Contributor(s)
Authors
Free shipping on orders over $75. Standard shipping takes 3-7 business days. Eligible items may be returned within 30 days of delivery. Conditions apply.
